Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MAP2K4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
OPN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP2U1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC30A5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP46 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
F8A3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC400927-CSNK1E - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101930416 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBAK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDX11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP4R3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRBA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SVIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEX11B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADCY1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YY1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DLAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MARCH6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on